Surveys
Public Perception of Peptide Regulation and Compounding Practices
A survey assessing beliefs, uncertainty, and perceived trade-offs related to evolving FDA oversight of peptide therapies. Keywords: peptides, FDA regulation, ...
Understanding of Clinical Evidence in Peptide and Hormone Use
Instructions: Please indicate your level of agreement with each statement using the following scale: Strongly Disagree | Disagree | Neutral ...
Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine
Public Perception Survey The Future of Peptides and Hormones in U.S. Medicine Context Statement (Intro for Respondents) Recent policy signals ...
Perceptions of Viral Wellness Practices on Social Media: A Likert-Scale Survey for Informed Readers
Daily Remedy Survey Instrument: Perceptions of Viral Wellness Practices on Social Media (Likert Statements) Response scale for all items: 1 ...
How Confident Are You in RFK Jr.’s Health Leadership?
Survey: Public Confidence in RFK Jr.’s Leadership in Health Policy Response scale for all items: Strongly disagree · Disagree · ...
AI in Healthcare Decision-Making
Response scale for each statement: 1 — Strongly disagree 2 — Disagree 3 — Neither agree nor disagree 4 — ...
Patient Survey: Understanding Healthcare Consumerism
Purpose: This survey explores how patients perceive healthcare consumerism, including choice, transparency, digital access, cost sensitivity, and trust. Responses reflect ...
Public Confidence in Proposed Changes to U.S. Vaccine Policy
The following questions ask about your level of agreement or confidence regarding proposed changes to U.S. vaccine policy. There are ...
What concerns you most about your healthcare?
For each statement below, please select the number that best reflects your feelings.
Perception vs. Comprehension: Public Understanding of the 2025 MAHA Report
This survey explores how the public engages with the May 2025 MAHA Report published by the White House. It aims ...
Should physicians apply HIPAA when asked by ICE to reveal patient information?
Should physicians apply HIPAA (Health Insurance Portability and Accountability Act) when asked by ICE (U.S. Immigration and Customs Enforcement) to ...
FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read more